Hear from expert faculty as they answer questions and discuss key considerations when selecting empiric antibiotic therapy in patients with HABP/VABP in the ICU.
In this episode, Marion Elligsen, BScPhm, MSc, RPh, ACPR; Keith S Kaye, MD, MPH; and Andrew Shorr, MD, MPH, MBA, discuss key considerations for selecting empiric antibiotic regimens in patients with HABP/VABP in the intensive care unit, including:
Faculty:
Marion Elligsen, BScPhm, MSc, RPh, ACPR
Practice-Based Researcher
Sunnybrook Research Institute
Antimicrobial Stewardship Pharmacy Lead
Department of Pharmacy
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
Keith S. Kaye, MD, MPH
Chief
Division of Allergy, Immunology and Infectious Diseases
Professor of Medicine
Rutgers Robert Wood Johnson Medical School
New Brunswick, New Jersey
Andrew Shorr, MD, MPH, MBA
Director
Pulmonary and Critical Care Medicine
Medstar Washington Hospital Center
Washington, DC
Content based on a CME program supported by an educational grant from Merck Sharp & Dohme Corp.
Link to full program:
https://bit.ly/3HaZpYw
Link to downloadable slideset:
https://bit.ly/3UxHoqr